(Q37842595)

24 August 2017

1 reference

title

Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5-HT3 receptor antagonists (English)

1 reference

24 August 2017

0 references

0 references

Matthias F Seidel

1

1 reference

24 August 2017

Wolfgang Müller

series ordinal

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

17 February 2011

1 reference

Expert Opinion on Pharmacotherapy

24 August 2017

published in

1 reference

24 August 2017

volume

12

1 reference

24 August 2017

issue

9

1 reference

24 August 2017

page(s)

1381-1391

1 reference

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Fibromyalgia: a rheumatologic diagnosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

The classification of fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Cell death during development of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Nerve growth factor in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Serotonin mediates PGE2 overexpression through 5-HT2A and 5-HT3 receptor subtypes in serum-free tissue culture of macrophage-like synovial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

The effects of 5HT3 receptor antagonist granisetron on inflammatory parameters and angiogenesis in the air-pouch model of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Role of 5-HT3 receptors in the mechanisms of central pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Treatment of fibromyalgia with tropisetron, a 5HT3 serotonin antagonist: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

5-HT(3) receptor antagonists and anxiety; a preclinical and clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

The influence of depression on the effect of Tropisetron in the therapy of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

The relationship between fibromyalgia and major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Treatment of fibromyalgia with antidepressants: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

The interaction of antidepressant drugs with central and peripheral (enteric) 5-HT3 and 5-HT4 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

A double-blind placebo controlled trial of fluoxetine in fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

An open-label clinical trial of milnacipran in fibromyalgia syndrome with co-morbid depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Pregabalin: a review of its use in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute neck or back pain with muscle spasm: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Treatment of fibromyalgia (fibrositis syndrome): a parallel double blind trial with carisoprodol, paracetamol and caffeine (Somadril comp) versus placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Open antero-lateral dislocation of the elbow. A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Pharmacological treatment of fibromyalgia syndrome: new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Operant behavioral treatment of fibromyalgia: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Abnormal affective modulation of somatosensory brain processing among patients with fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Chronic pain may change the structure of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Difference in pain relief after trigger point injections in myofascial pain patients with and without fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

The influence of the 5‐HT3receptor antagonist tropisetron on pain in fibromyalgia: a functional magnetic resonance imaging pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

10.1517/14656566.2011.557362

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference